著者

山本 俊正 Toshimasa Yamamoto

雑誌

関西学院大学キリスト教と文化研究 = Kwansei Gakuin University journal of studies on Christianity and culture (ISSN:13454382)

巻号頁・発行日

no.13, pp.123-143, 2012-03-31

著者

山本 俊正 Toshimasa Yamamoto

雑誌

商学論究 (ISSN:02872552)

巻号頁・発行日

vol.63, no.4, pp.23-40, 2016-03-10

著者

Yasuo Ito Takashi Mitsufuji Yoshio Asano Tomokazu Shimazu Yuji Kato Norio Tanahashi Yuichi Maruki Fumihiko Sakai Toshimasa Yamamoto Nobuo Araki

出版者

一般社団法人 日本内科学会

雑誌

Internal Medicine (ISSN:09182918)

巻号頁・発行日

pp.8865-17, (Released:2017-09-06)

参考文献数

13

被引用文献数

9

---

Objective Naratriptan has been reported to reduce the frequency of cluster headache. The purpose of this study was to determine whether naratriptan is effective as a prophylactic treatment for cluster headache in Japan. Methods We retrospectively reviewed all 43 patients with cluster headache who received preventive treatment with naratriptan from April 2009 to April 2015. The International Classification of Headache Disorders, 3rd Edition (beta version) (ICHD-3 beta) was used to diagnose cluster headache. This study was conducted at 3 centers (Department of Neurology, Saitama Medical University; Saitama Neuropsychiatric Institute; Saitama Medical University International Medical Center). Patients were recruited from these specialized headache outpatient centers. Naratriptan was taken before the patient went to bed. Results The study population included 30 men (69.8%) and 13 women (30.2%). Twenty-two cases received other preventive treatments (51.2%), while 21 cases only received naratriptan (48.8%). Among the 43 cases, 37 patients (86.0%) achieved an improvement of cluster headache on naratriptan. Conclusion Naratriptan has been suggested as a preventive medicine for cluster headache because of the longer the biological half-life in comparison to other triptans. The internal use of naratriptan 2 hours before attacks appears to achieve a good response in patients with cluster headache.